RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy10341
         (213 letters)



>gnl|CDD|212529 cd10005, HDAC3, Histone deacetylase 3 (HDAC3).  HDAC3 is a
           Zn-dependent class I histone deacetylase that catalyzes
           hydrolysis of N(6)-acetyl-lysine residue of a histone to
           yield a deacetylated histone (EC 3.5.1.98). Histone
           acetylation/deacetylation process is important for
           mediation of transcriptional regulation of many genes.
           In order to target specific chromatin regions, HDAC3 can
           interact with DNA-binding proteins (transcriptional
           factors) either directly or after forming complexes with
           a number of other proteins, as observed for the
           SMPT/N-CoR complex which recruits human HDAC3 to
           specific chromatin loci and activates deacetylation.
           Human HDAC3 is also involved in deacetylation of
           non-histone substrates such as RelA, SPY and p53
           factors. This protein can also down-regulate p53
           function and subsequently modulate cell growth and
           apoptosis. This gene is therefore regarded as a
           potential tumor suppressor gene. HDAC3 plays a role in
           various physiological processes, including subcellular
           protein localization, cell cycle progression, cell
           differentiation, apoptosis and survival. HDAC3 has been
           found to be overexpressed in some tumors including
           leukemia, lung carcinoma, colon cancer and maxillary
           carcinoma. Thus, inhibitors precisely targeting HDAC3
           (in some cases together with retinoic acid or
           hyperthermia) could be a therapeutic drug option.
          Length = 381

 Score =  199 bits (507), Expect = 8e-63
 Identities = 77/123 (62%), Positives = 100/123 (81%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVNEEIS 95
           LG   LG F+L+ KGHGECV+FV+  N+PLLVLGGGGYT+RNVARCWTYETSLLV+EEIS
Sbjct: 259 LGCDRLGCFNLSIKGHGECVEFVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVDEEIS 318

Query: 96  NDIPDSLYKDFFQPDYNLHPEFVHKHDNANSKQYLELITKTVYDNLKMVAFSPSVQMQDM 155
           N++P + Y ++F PD+ LHP+   + +N NSKQYL+ I +TV++NLKM+  +PSVQMQD+
Sbjct: 319 NELPYNEYFEYFAPDFTLHPDVSTRIENQNSKQYLDQIRQTVFENLKMLNHAPSVQMQDV 378

Query: 156 IGD 158
             D
Sbjct: 379 PPD 381


>gnl|CDD|240251 PTZ00063, PTZ00063, histone deacetylase; Provisional.
          Length = 436

 Score =  140 bits (354), Expect = 1e-39
 Identities = 65/146 (44%), Positives = 94/146 (64%), Gaps = 7/146 (4%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVN--EE 93
           L G  LG+F+LT KGH  CV+FVR LN+PLLVLGGGGYT+RNVARCW YET +++N  +E
Sbjct: 263 LTGDRLGRFNLTIKGHAACVEFVRSLNIPLLVLGGGGYTIRNVARCWAYETGVILNKHDE 322

Query: 94  ISNDIPDSLYKDFFQPDYNLH--PEFVHKHDNANSKQYLELITKTVYDNLKMVAFSPSVQ 151
           +S+ I  + Y D++ PD+ LH  P  +    N NS ++LE I   + +NL+ +  +P VQ
Sbjct: 323 MSDQISLNDYYDYYAPDFQLHLQPSNI---PNYNSPEHLEKIKVKILENLRYLEHAPGVQ 379

Query: 152 MQDMIGDVFTRDIGAVLDEMDPDIKN 177
              +  D F RDI    ++   ++ +
Sbjct: 380 FAYVPPDFFDRDIDDEDEKNQYELSD 405


>gnl|CDD|212528 cd10004, RPD3-like, reduced potassium dependency-3 (RPD3)-like.
           Proteins of the Rpd3-like family are class I
           Zn-dependent Histone deacetylases that catalyze
           hydrolysis of an N(6)-acetyl-lysine residue of a histone
           to yield a deacetylated histone (EC 3.5.1.98). RPD3 is
           the yeast homolog of class I HDACs. The main function of
           RPD3-like group members is regulation of a number of
           different processes through protein (mostly different
           histones) modification (deacetylation). This group
           includes fungal RPD3 and acts via the formation of large
           multiprotein complexes. Members of this group are
           involved in cell cycle regulation, DNA damage response,
           embryonic development and cytokine signaling important
           for immune response. Histone deacetylation by yeast RPD3
           represses genes regulated by the Ash1 and Ume6
           DNA-binding proteins. In mammals, they are known to be
           involved in progression of various tumors. Specific
           inhibitors of mammalian histone deacetylases could be a
           therapeutic drug option.
          Length = 375

 Score =  134 bits (339), Expect = 6e-38
 Identities = 59/118 (50%), Positives = 81/118 (68%), Gaps = 1/118 (0%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVNEEIS 95
           L G  LG F+L+ KGH  CV FV+  N+P+LVLGGGGYT+RNVAR W +ET LL  EE+ 
Sbjct: 259 LSGDRLGCFNLSMKGHANCVNFVKSFNLPMLVLGGGGYTMRNVARTWAFETGLLAGEELD 318

Query: 96  NDIPDSLYKDFFQPDYNLHPEFVHKHDNANSKQYLELITKTVYDNLKMVAFSPSVQMQ 153
            D+P + Y +++ PDY L+       +N N+ +YL+ IT  V +NL+  +F+PSVQMQ
Sbjct: 319 KDLPYNEYYEYYGPDYELNVR-PSNMENHNTPEYLDKITTAVIENLRNTSFAPSVQMQ 375


>gnl|CDD|212534 cd10010, HDAC1, Histone deacetylase 1 (HDAC1).  Histone deacetylase
           1 (HDAC1) is a Zn-dependent class I enzyme that
           catalyzes hydrolysis of N(6)-acetyl-lysine residue of a
           histone to yield a deacetylated histone (EC 3.5.1.98).
           Histone acetylation/deacetylation process is important
           for mediation of transcriptional regulation of many
           genes. HDAC1 is involved in regulation through
           association with DNA binding proteins to target specific
           chromatin regions. In particular, HDAC1 appears to play
           a major role in pre-implantation embryogenesis in
           establishing a repressive chromatin state. Its
           interaction with retinoblastoma tumor-suppressor protein
           is essential in the control of cell proliferation and
           differentiation. Together with metastasis-associated
           protein-2 (MTA2), it deacetylates p53, thereby
           modulating its effect on cell growth and apoptosis. It
           participates in DNA-damage response, along with HDAC2;
           together, they promote DNA non-homologous end-joining.
           HDAC1 is also involved in tumorogenesis; its
           overexpression modulates cancer progression. Specific
           inhibitors of HDAC1 are currently used in cancer
           therapy.
          Length = 371

 Score =  120 bits (302), Expect = 1e-32
 Identities = 54/109 (49%), Positives = 80/109 (73%), Gaps = 1/109 (0%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVNEEIS 95
           L G  LG F+LT KGH +CV+FV+  N+P+L+LGGGGYT+RNVARCWTYET++ ++ EI 
Sbjct: 263 LSGDRLGCFNLTIKGHAKCVEFVKSFNLPMLMLGGGGYTIRNVARCWTYETAVALDSEIP 322

Query: 96  NDIPDSLYKDFFQPDYNLHPEFVHKHDNANSKQYLELITKTVYDNLKMV 144
           N++P + Y ++F PD+ LH        N N+ +YLE I + +++NL+M+
Sbjct: 323 NELPYNDYFEYFGPDFKLHIS-PSNMTNQNTNEYLEKIKQRLFENLRML 370


>gnl|CDD|212535 cd10011, HDAC2, Histone deacetylase 2 (HDAC2).  Histone deacetylase
           2 (HDAC2) is a Zn-dependent class I enzyme that
           catalyzes hydrolysis of N(6)-acetyl-lysine residue of a
           histone to yield a deacetylated histone (EC 3.5.1.98).
           Histone acetylation/deacetylation process is important
           for mediation of transcriptional regulation of many
           genes. HDAC2 is involved in regulation through
           association with DNA binding proteins to target specific
           chromatin regions. It forms transcriptional repressor
           complexes by associating with several proteins,
           including the mammalian zinc-finger transcription factor
           YY1, thus playing an important role in transcriptional
           regulation, cell cycle progression and developmental
           events. Additionally, a few non-histone HDAC2 substrates
           have been found. HDAC2 plays a role in embryonic
           development and cytokine signaling important for immune
           response, and is over-expressed in several solid tumors
           including oral, prostate, ovarian, endometrial and
           gastric cancer. It participates in DNA-damage response,
           along with HDAC1; together, they can promote DNA
           non-homologous end-joining. HDAC2 is considered an
           important cancer prognostic marker. Inhibitors
           specifically targeting HDAC2 could be a therapeutic drug
           option.
          Length = 366

 Score =  117 bits (293), Expect = 2e-31
 Identities = 53/109 (48%), Positives = 79/109 (72%), Gaps = 1/109 (0%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVNEEIS 95
           L G  LG F+LT KGH +CV+ V+  N+PLL+LGGGGYT+RNVARCWTYET++ ++ EI 
Sbjct: 259 LSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIP 318

Query: 96  NDIPDSLYKDFFQPDYNLHPEFVHKHDNANSKQYLELITKTVYDNLKMV 144
           N++P + Y ++F PD+ LH        N N+ +Y+E I + +++NL+M+
Sbjct: 319 NELPYNDYFEYFGPDFKLHIS-PSNMTNQNTPEYMEKIKQRLFENLRML 366


>gnl|CDD|212524 cd10000, HDAC8, Histone deacetylase 8 (HDAC8).  HDAC8 is a
           Zn-dependent class I histone deacetylase that catalyzes
           hydrolysis of an N(6)-acetyl-lysine residue of a histone
           to yield a deacetylated histone (EC 3.5.1.98). Histone
           acetylation/deacetylation process is important for
           mediation of transcriptional regulation of many genes.
           Histone deacetylases usually act via association with
           DNA binding proteins to target specific chromatin
           regions. HDAC8 is found in human cytoskeleton-bound
           protein fraction and insoluble cell pellets. It plays a
           crucial role in intramembraneous bone formation;
           germline deletion of HDAC8 is detrimental to skull bone
           formation. HDAC8 is possibly associated with the smooth
           muscle actin cytockeleton and may regulate the
           contractive capacity of smooth muscle cells. HDAC8 is
           also involved in the metabolic control of the estrogen
           receptor related receptor (ERR)-alpha/peroxisome
           proliferator activated receptor (PPAR) gamma coactivator
           1 alpha (PGC1-alpha) transcriptional complex as well as
           in the development of neuroblastoma and T-cell lymphoma.
           HDAC8-selective small-molecule inhibitors could be a
           therapeutic drug option for these diseases.
          Length = 364

 Score =  108 bits (272), Expect = 3e-28
 Identities = 52/116 (44%), Positives = 68/116 (58%), Gaps = 11/116 (9%)

Query: 35  VLGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLLVNEEI 94
            L G  +G F+LT  G G+C+K+V    +P L+LGGGGY L N ARCWTY T L++ E +
Sbjct: 255 TLAGDPMGAFNLTPVGIGKCLKYVLGWKLPTLILGGGGYNLANTARCWTYLTGLILGEPL 314

Query: 95  SNDIPDSLYKDFFQ---PDYNLH--PEFVHKHDNANSKQYLELITKTVYDNLKMVA 145
           S+DIPD    +FF    PDY L   P       + N  QY+E I +T+  NLK V 
Sbjct: 315 SSDIPDH---EFFTSYGPDYELEISPS---LRPDLNEDQYIEKILETIKGNLKNVV 364


>gnl|CDD|212517 cd09991, HDAC_classI, Class I histone deacetylases.  Class I
           histone deacetylases (HDACs) are Zn-dependent enzymes
           that catalyze hydrolysis of N(6)-acetyl-lysine residues
           in histone amino termini to yield a deacetylated histone
           (EC 3.5.1.98). Enzymes belonging to this group
           participate in regulation of a number of processes
           through protein (mostly different histones) modification
           (deacetylation). Class I histone deacetylases in general
           act via the formation of large multiprotein complexes.
           This group includes animal HDAC1, HDAC2, HDAC3, HDAC8,
           fungal RPD3, HOS1 and HOS2, plant HDA9, protist,
           archaeal and bacterial (AcuC) deacetylases. Members of
           this class are involved in cell cycle regulation, DNA
           damage response, embryonic development, cytokine
           signaling important for immune response and in
           posttranslational control of the acetyl coenzyme A
           synthetase. In mammals, they are known to be involved in
           progression of various tumors. Specific inhibitors of
           mammalian histone deacetylases are an emerging class of
           promising novel anticancer drugs.
          Length = 306

 Score =  107 bits (269), Expect = 3e-28
 Identities = 39/54 (72%), Positives = 46/54 (85%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLL 89
           L G  LG F+L+ KGH +CVKFV+  N+PLLVLGGGGYTLRNVARCWTYET++L
Sbjct: 253 LAGDRLGCFNLSIKGHAKCVKFVKSFNIPLLVLGGGGYTLRNVARCWTYETAVL 306


>gnl|CDD|212540 cd11598, HDAC_Hos2, Class I histone deacetylases including ScHos2
           and SpPhd1.  This subfamily includes Class I histone
           deacetylase (HDAC) Hos2 from Saccharomyces cerevisiae as
           well as a histone deacetylase Phd1 from
           Schizosaccharomyces pombe. Hos2 binds to the coding
           regions of genes during gene activation, specifically it
           deacetylates the lysines in H3 and H4 histone tails. It
           is preferentially associated with genes of high activity
           genome-wide and is shown to be necessary for efficient
           transcription. Thus, Hos2 is directly required for gene
           activation in contrast to other class I histone
           deacetylases. Protein encoded by phd1 is inhibited by
           trichostatin A (TSA), a specific inhibitor of histone
           deacetylase, and is involved in the meiotic cell cycle
           in S. pombe. Class 1 HDACs are Zn-dependent enzymes that
           catalyze hydrolysis of N(6)-acetyl-lysine residues in
           histone amino termini to yield a deacetylated histone
           (EC 3.5.1.98).
          Length = 311

 Score = 96.4 bits (240), Expect = 5e-24
 Identities = 34/54 (62%), Positives = 41/54 (75%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLL 89
           LGG  LGQF+L  K HG CVKFV+   +P+LV+GGGGYT RNVAR W YET++ 
Sbjct: 258 LGGDRLGQFNLNIKAHGACVKFVKSFGIPMLVVGGGGYTPRNVARAWCYETAVA 311


>gnl|CDD|240374 PTZ00346, PTZ00346, histone deacetylase; Provisional.
          Length = 429

 Score = 78.9 bits (194), Expect = 3e-17
 Identities = 33/54 (61%), Positives = 43/54 (79%)

Query: 36  LGGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARCWTYETSLL 89
           L G  LG  +L++ GHG+CV+ VRDL +P+L LGGGGYT+RNVA+ W YETS+L
Sbjct: 281 LAGDRLGLLNLSSFGHGQCVQAVRDLGIPMLALGGGGYTIRNVAKLWAYETSIL 334


>gnl|CDD|223201 COG0123, AcuC, Deacetylases, including yeast histone deacetylase
           and acetoin utilization protein [Chromatin structure and
           dynamics / Secondary metabolites biosynthesis,
           transport, and catabolism].
          Length = 340

 Score = 60.1 bits (146), Expect = 7e-11
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 8/79 (10%)

Query: 41  LGQFSLTTKGHGECVKFVRDL----NVPLLVLGGGGYTLRNVARCWTYETSLL---VNEE 93
           LG+ +LT +G+ +  + VR L      P++ +  GGY L  +AR      + L   V EE
Sbjct: 257 LGRLNLTEEGYAKIGRAVRKLAEGYGGPVVAVLEGGYNLDALARSLVAFLAGLAGLVEEE 316

Query: 94  ISNDIP-DSLYKDFFQPDY 111
           +   +P D   +  F+ DY
Sbjct: 317 LEEPLPEDLELRRAFRADY 335


>gnl|CDD|216151 pfam00850, Hist_deacetyl, Histone deacetylase domain.  Histones can
           be reversibly acetylated on several lysine residues.
           Regulation of transcription is caused in part by this
           mechanism. Histone deacetylases catalyze the removal of
           the acetyl group. Histone deacetylases are related to
           other proteins.
          Length = 300

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 16/53 (30%), Positives = 27/53 (50%), Gaps = 4/53 (7%)

Query: 41  LGQFSLTTKGHGECVKFVRDL----NVPLLVLGGGGYTLRNVARCWTYETSLL 89
           LG  +LTT+G+ E  + + +L      P++ +  GGY L  +AR      + L
Sbjct: 247 LGGLNLTTEGYAERTRLLLELADAYGGPVVSVLEGGYNLDALARSAAAVLAGL 299


>gnl|CDD|212512 cd09301, HDAC, Histone deacetylase (HDAC) classes I, II, IV and
           related proteins.  The HDAC/HDAC-like family includes
           Zn-dependent histone deacetylase classes I, II and IV
           (class III HDACs, also called sirtuins, are
           NAD-dependent and structurally unrelated, and therefore
           not part of this family). Histone deacetylases catalyze
           hydrolysis of N(6)-acetyl-lysine residues in histone
           amino termini to yield a deacetylated histone (EC
           3.5.1.98), as opposed to the acetylation reaction by
           some histone acetyltransferases (EC 2.3.1.48).
           Deacetylases of this family are involved in signal
           transduction through histone and other protein
           modification, and can repress/activate transcription of
           a number of different genes. They usually act via the
           formation of large multiprotein complexes. They are
           involved in various cellular processes, including cell
           cycle regulation, DNA damage response, embryonic
           development, cytokine signaling important for immune
           response and post-translational control of the acetyl
           coenzyme A synthetase. In mammals, they are known to be
           involved in progression of different tumors. Specific
           inhibitors of mammalian histone deacetylases are an
           emerging class of promising novel anticancer drugs.
          Length = 279

 Score = 56.7 bits (137), Expect = 8e-10
 Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 2/54 (3%)

Query: 38  GGGLGQFSLTTKGHGECVKFVRDLN--VPLLVLGGGGYTLRNVARCWTYETSLL 89
           G  LG F+L+ KG  +  + V++     P+L++ GGGY     AR WT     L
Sbjct: 226 GDRLGGFNLSEKGFVKLAEIVKEFARGGPILMVLGGGYNPEAAARIWTAIIKEL 279


>gnl|CDD|212520 cd09994, HDAC_AcuC_like, Class I histone deacetylase AcuC (Acetoin
           utilization protein)-like enzymes.  AcuC (Acetoin
           utilization protein) is a class I deacetylase found only
           in bacteria and is involved in post-translational
           control of the acetyl-coenzyme A synthetase (AcsA).
           Deacetylase AcuC works in coordination with deacetylase
           SrtN (class III), possibly to maintain AcsA in active
           (deacetylated) form and let the cell grow under low
           concentration of acetate. B. subtilis AcuC is a member
           of operon acuABC; this operon is repressed by the
           presence of glucose and does not show induction by
           acetoin; acetoin is a bacterial fermentation product
           that can be converted to acetate via the butanediol
           cycle in absence of other carbon sources. Inactivation
           of AcuC leads to slower growth and lower cell yield
           under low-acetate conditions in Bacillus subtilis. In
           general, Class I histone deacetylases (HDACs) are
           Zn-dependent enzymes that catalyze hydrolysis of
           N(6)-acetyl-lysine residues in histone amino termini to
           yield a deacetylated histone (EC 3.5.1.98). Enzymes
           belonging to this group participate in regulation of a
           number of processes through protein (mostly different
           histones) modification (deacetylation). Class I histone
           deacetylases in general act via the formation of large
           multiprotein complexes. Members of this class are
           involved in cell cycle regulation, DNA damage response,
           embryonic development, cytokine signaling important for
           immune response and in posttranslational control of the
           acetyl coenzyme A synthetase.
          Length = 313

 Score = 55.6 bits (135), Expect = 2e-09
 Identities = 16/48 (33%), Positives = 23/48 (47%), Gaps = 5/48 (10%)

Query: 41  LGQFSLTTKGHGECVKFVRDL-----NVPLLVLGGGGYTLRNVARCWT 83
           L   +L+ + +   V+ +R+L         L LGGGGY    VAR W 
Sbjct: 260 LTHLNLSNRAYRAAVRRIRELADEYCGGRWLALGGGGYNPDVVARAWA 307


>gnl|CDD|212543 cd11680, HDAC_Hos1, Class I histone deacetylases Hos1 and related
           proteins.  Saccharomyces cerevisiae Hos1 is responsible
           for Smc3 deacetylation. Smc3 is an important player
           during the establishment of sister chromatid cohesion.
           Hos1 belongs to the class I histone deacetylases
           (HDACs). HDACs are Zn-dependent enzymes that catalyze
           hydrolysis of N(6)-acetyl-lysine residues in histone
           amino termini to yield a deacetylated histone (EC
           3.5.1.98). Enzymes belonging to this group participate
           in regulation of a number of processes through protein
           (mostly different histones) modification
           (deacetylation). Class I histone deacetylases in general
           act via the formation of large multiprotein complexes.
           Other class I HDACs are animal HDAC1, HDAC2, HDAC3,
           HDAC8, fungal RPD3 and HOS2, plant HDA9, protist,
           archaeal and bacterial (AcuC) deacetylases. Members of
           this class are involved in cell cycle regulation, DNA
           damage response, embryonic development, cytokine
           signaling important for immune response and in
           posttranslational control of the acetyl coenzyme A
           synthetase.
          Length = 294

 Score = 53.8 bits (130), Expect = 9e-09
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 7/63 (11%)

Query: 34  LVLGGGGL-----GQFSLTTKGHGECVKFVRD--LNVPLLVLGGGGYTLRNVARCWTYET 86
           +  G  GL      +++LT +G+G  ++ +     + P L+LGGGGY     AR WTY T
Sbjct: 232 IQCGCDGLSGDPHKEWNLTIRGYGSVIELLLKEFKDKPTLLLGGGGYNHTEAARAWTYLT 291

Query: 87  SLL 89
           S++
Sbjct: 292 SMV 294


>gnl|CDD|212513 cd09987, Arginase_HDAC, Arginase-like and histone-like hydrolases. 
           Arginase-like/histone-like hydrolase superfamily
           includes metal-dependent enzymes that belong to
           Arginase-like amidino hydrolase family and
           histone/histone-like deacetylase class I, II, IV family,
           respectively. These enzymes catalyze hydrolysis of amide
           bond. Arginases are known to be involved in control of
           cellular levels of arginine and ornithine, in histidine
           and arginine degradation and in clavulanic acid
           biosynthesis. Deacetylases play a role in signal
           transduction through histone and/or other protein
           modification and can repress/activate transcription of a
           number of different genes. They participate in different
           cellular processes including cell cycle regulation, DNA
           damage response, embryonic development, cytokine
           signaling important for immune response and
           post-translational control of the acetyl coenzyme A
           synthetase. Mammalian histone deacetyases are known to
           be involved in progression of different tumors. Specific
           inhibitors of mammalian histone deacetylases are an
           emerging class of promising novel anticancer drugs.
          Length = 217

 Score = 36.2 bits (84), Expect = 0.006
 Identities = 9/55 (16%), Positives = 16/55 (29%), Gaps = 4/55 (7%)

Query: 37  GGGGLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTL----RNVARCWTYETS 87
           G G  G   L+ +      + +   N+ + +       L       AR     T 
Sbjct: 161 GTGTPGPGGLSYREGLYITERIAKTNLVVGLDIVEVNPLLDETGRTARLAAALTL 215


>gnl|CDD|212525 cd10001, HDAC_classII_APAH, Histone deacetylase class IIa.  This
           subfamily includes bacterial acetylpolyamine
           amidohydrolase (APAH) as well as other Class II histone
           deacetylase (HDAC) and related proteins. Deacetylases of
           class II are Zn-dependent enzymes that catalyze
           hydrolysis of N(6)-acetyl-lysine residues of histones
           (EC 3.5.1.98) and possibly other proteins to yield
           deacetylated histones/other proteins. Mycoplana ramosa
           APAH exhibits broad substrate specificity and catalyzes
           the deacetylation of polyamines such as putrescine,
           spermidine, and spermine by cleavage of a non-peptide
           amide bond.
          Length = 298

 Score = 32.9 bits (76), Expect = 0.094
 Identities = 11/42 (26%), Positives = 20/42 (47%)

Query: 40  GLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLRNVARC 81
            L  F LTT+ +    + +  L +P + +  GGY +  + R 
Sbjct: 248 PLSDFKLTTEDYARIGRRIAALGLPTVFVQEGGYNVDALGRN 289



 Score = 30.2 bits (69), Expect = 0.77
 Identities = 11/35 (31%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 6   HDRLGQFSLTTKGHGECVKFVRDLNVP-LLVLGGG 39
            D L  F LTT+ +    + +  L +P + V  GG
Sbjct: 246 GDPLSDFKLTTEDYARIGRRIAALGLPTVFVQEGG 280


>gnl|CDD|212519 cd09993, HDAC_classIV, Histone deacetylase class IV also known as
           histone deacetylase 11.  Class IV histone deacetylases
           (HDAC11; EC 3.5.1.98) are predicted Zn-dependent
           enzymes. This class includes animal HDAC11, plant HDA2
           and related bacterial deacetylases. Enzymes in this
           subfamily participate in regulation of a number of
           different processes through protein modification
           (deacetylation). They catalyze hydrolysis of
           N(6)-acetyl-lysine of histones (or other proteins) to
           yield a deacetylated proteins. Histone deacetylases
           often act as members of large multi-protein complexes
           such as mSin3A or SMRT/N-CoR. Human HDAC11 does not
           associate with them but can interact with HDAC6 in vivo.
           It has been suggested that HDAC11 and HDAC6 may use
           non-histone proteins as their substrates and play a role
           other than to directly modulate chromatin structure. In
           normal tissues, expression of HDAC11 is limited to
           kidney, heart, brain, skeletal muscle and testis,
           suggesting that its function might be tissue-specific.
           In mammals, HDAC11 proteins are known to be involved in
           progression of various tumors. HDAC11 plays an essential
           role in regulating OX40 ligand (OX40L) expression in
           Hodgkin lymphoma (HL); selective inhibition of HDAC11
           expression significantly up-regulates OX40L and induces
           apoptosis in HL cell lines. Thus, inhibition of HDAC11
           could be a therapeutic drug option for antitumor immune
           response in HL patients.
          Length = 275

 Score = 31.3 bits (72), Expect = 0.28
 Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 29/74 (39%)

Query: 7   DRLGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGLGQFSLTTKGHGECVKFVRDLNVPLL 66
           DRLG+ SL+ +G  E     RD     LVL                   +F R   +P+ 
Sbjct: 222 DRLGRLSLSLEGLRE-----RDR----LVL-------------------RFARARGIPVA 253

Query: 67  VLGGGGYTLRNVAR 80
           ++ GGGY+ R++AR
Sbjct: 254 MVLGGGYS-RDIAR 266


>gnl|CDD|237777 PRK14652, PRK14652, UDP-N-acetylenolpyruvoylglucosamine reductase;
           Provisional.
          Length = 302

 Score = 30.6 bits (69), Expect = 0.50
 Identities = 26/86 (30%), Positives = 34/86 (39%), Gaps = 11/86 (12%)

Query: 23  VKFVRDLNVPLLVLGGGG------LGQFSLTTKGHGECVKFVRDLNVPLLVLGGGGYTLR 76
           ++ VR+L VPL +LGGG        G   +  +   +      D     LVLG G    R
Sbjct: 52  LRAVRELGVPLSILGGGANTLVADAGVRGVVLRLPQDFPGESTDGGR--LVLGAGAPISR 109

Query: 77  NVARCWTYETSLLVNEEISNDIPDSL 102
             AR        LV  E    IP +L
Sbjct: 110 LPARA---HAHGLVGMEFLAGIPGTL 132


>gnl|CDD|234053 TIGR02903, spore_lon_C, ATP-dependent protease, Lon family.
           Members of this protein family resemble the widely
           distributed ATP-dependent protease La, also called Lon
           and LonA. It resembles even more closely LonB, which is
           a LonA paralog found in genomes if and only if the
           species is capable of endospore formation (as in
           Bacillus subtilis, Clostridium tetani, and select other
           members of the Firmicutes) and expressed specifically in
           the forespore compartment. Members of this family are
           restricted to a subset of spore-forming species, and are
           very likely to participate in the program of endospore
           formation. We propose the designation LonC [Protein
           fate, Degradation of proteins, peptides, and
           glycopeptides, Cellular processes, Sporulation and
           germination].
          Length = 615

 Score = 30.9 bits (70), Expect = 0.52
 Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 7/48 (14%)

Query: 157 GDVFTRDIGAVLDEMDPDIKNPQLE--EDKRVDPANEFYDGDNDQDAP 202
           G +F  +IG    E+DP ++N  L+  EDKRV+ ++ +YD D D + P
Sbjct: 267 GVLFIDEIG----ELDPLLQNKLLKVLEDKRVEFSSSYYDPD-DPNVP 309


>gnl|CDD|182141 PRK09913, PRK09913, putative fructose-like phosphotransferase
           system subunit EIIA; Provisional.
          Length = 148

 Score = 28.7 bits (64), Expect = 1.5
 Identities = 7/25 (28%), Positives = 16/25 (64%)

Query: 113 LHPEFVHKHDNANSKQYLELITKTV 137
           +H +F+H+    ++ Q L L+ +T+
Sbjct: 122 IHQDFIHQLKQGDTDQVLALLNQTL 146


>gnl|CDD|176958 CHL00015, ndhE, NADH dehydrogenase subunit 4L.
          Length = 101

 Score = 27.7 bits (62), Expect = 2.1
 Identities = 13/38 (34%), Positives = 20/38 (52%), Gaps = 2/38 (5%)

Query: 130 LELITKTVYDNLKMVAFSPSVQMQDMIGDVFTRDIGAV 167
           LELI   V  N+  V FS     + + GD+F+  + A+
Sbjct: 34  LELILNAV--NINFVTFSDFFDSRQLKGDIFSIFVIAI 69


>gnl|CDD|233194 TIGR00930, 2a30, K-Cl cotransporter.  [Transport and binding
           proteins, Other].
          Length = 953

 Score = 28.5 bits (64), Expect = 3.4
 Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 12/92 (13%)

Query: 129 YLELITKTVYDNLKMVAFSPSVQMQDMIGD-----VFTRD--IGAVLDEMDPDIK-NPQL 180
           YL L TK V+   K+  F  + +      +            I A +  +  DI   PQ 
Sbjct: 780 YL-LTTKKVWKKCKIRIFVGAQKDDRSEQEKKDMATLLYKFRIDAEVIVVLMDINAKPQT 838

Query: 181 EEDKRVDPANE---FYDGDNDQDAPDTEMSWG 209
           E  +  +        +  + D++A D +M+W 
Sbjct: 839 ESMEAFEEMIRPFRLHKTEKDREAKDPKMTWT 870


>gnl|CDD|129966 TIGR00888, guaA_Nterm, GMP synthase (glutamine-hydrolyzing),
          N-terminal domain or A subunit.  This protein of purine
          de novo biosynthesis is well-conserved. However, it
          appears to split into two separate polypeptide chains
          in most of the Archaea. This N-terminal region would be
          the smaller subunit [Purines, pyrimidines, nucleosides,
          and nucleotides, Purine ribonucleotide biosynthesis].
          Length = 188

 Score = 27.3 bits (61), Expect = 4.4
 Identities = 10/41 (24%), Positives = 20/41 (48%), Gaps = 3/41 (7%)

Query: 26 VRDLNVPLLVLGGGGLGQFSLTTKGHGECVKFVRDLNVPLL 66
          +R+ N   ++L GG     S+  +      + + +L VP+L
Sbjct: 37 IREKNPKGIILSGG---PSSVYAENAPRADEKIFELGVPVL 74


>gnl|CDD|183743 PRK12785, fliL, flagellar basal body-associated protein FliL;
          Reviewed.
          Length = 166

 Score = 27.3 bits (61), Expect = 4.9
 Identities = 12/21 (57%), Positives = 15/21 (71%)

Query: 33 LLVLGGGGLGQFSLTTKGHGE 53
          +L+LGGGG G F   + GHGE
Sbjct: 34 VLLLGGGGGGFFFFFSHGHGE 54


>gnl|CDD|99794 cd06197, FNR_like_2, FAD/NAD(P) binding domain of  ferredoxin
           reductase-like proteins. Ferredoxin reductase (FNR) was
           intially identified as a chloroplast reductase activity,
           catalyzing the electron transfer from reduced
           iron-sulfur protein ferredoxin to NADP+ as the final
           step in the electron transport mechanism of photosystem
           I. FNR transfers electrons from reduced ferredoxin to
           FAD (forming FADH2 via a semiquinone intermediate) and
           then transfers a hydride ion to convert NADP+ to NADPH.
           FNR has since been shown to utilize a variety of
           electron acceptors and donors and have a variety of
           physiological  functions in a variety of organisms
           including nitrogen assimilation, dinitrogen fixation,
           steroid hydroxylation, fatty acid metabolism, oxygenase
           activity, and methane assimilation. FNR has an
           NAD(P)-binding sub-domain of the alpha/beta class and a
           discrete (usually N-terminal) flavin sub-domain which
           varies in orientation with respect  to the NAD(P)
           binding domain. The N-terminal moeity may contain a
           flavin prosthetic group (as in flavoenzymes) or use
           flavin as a substrate. Because flavins such as FAD can
           exist in oxidized, semiquinone (one-electron reduced),
           or fully reduced hydroquinone forms, FNR can interact
           with one and two electron carriers. FNR has a strong
           preference for NADP(H) vs NAD(H).
          Length = 220

 Score = 27.4 bits (61), Expect = 5.3
 Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 14/69 (20%)

Query: 2   WTLS-----HDRLGQFSLTTKGHGECVKFVRDLN-------VPLLVLGGGGLGQFSLTTK 49
           +T+S          +F +T +  G    F+  +        + + VLG G  G+F+L+  
Sbjct: 63  FTVSSAPPHDPATDEFEITVRKKGPVTGFLFQVARRLREQGLEVPVLGVG--GEFTLSLP 120

Query: 50  GHGECVKFV 58
           G G   K V
Sbjct: 121 GEGAERKMV 129



 Score = 27.0 bits (60), Expect = 7.7
 Identities = 11/46 (23%), Positives = 19/46 (41%), Gaps = 8/46 (17%)

Query: 42  GQFSLTTKGHGECVKFVRDLN-------VPLLVLG-GGGYTLRNVA 79
            +F +T +  G    F+  +        + + VLG GG +TL    
Sbjct: 76  DEFEITVRKKGPVTGFLFQVARRLREQGLEVPVLGVGGEFTLSLPG 121


>gnl|CDD|182105 PRK09840, PRK09840, catecholate siderophore receptor Fiu;
           Provisional.
          Length = 761

 Score = 27.8 bits (62), Expect = 5.3
 Identities = 11/34 (32%), Positives = 14/34 (41%), Gaps = 1/34 (2%)

Query: 173 PDIKNPQLEEDKRVDPANEFYDGDNDQDAPDTEM 206
           P      L    +VD  N FY  D+D D   T+ 
Sbjct: 277 PSAGRAALNHAGKVDTHN-FYGTDSDYDDSTTDT 309


>gnl|CDD|221109 pfam11428, DUF3196, Protein of unknown function (DUF3196).  This
           proteins is the product of the gene MPN330 and is
           thought to involved in a cellular function that has yet
           to be characterized. The proteins has 11 helices and a
           novel fold. No function is currently known for this
           protein.
          Length = 286

 Score = 27.1 bits (60), Expect = 6.5
 Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 8/60 (13%)

Query: 90  VNEEISNDIPDSLYKDFF--QPDYNLHP------EFVHKHDNANSKQYLELITKTVYDNL 141
              E +N+I D+L   +F   PD+N++       ++V          Y + I K + D +
Sbjct: 221 SLLEFANEIIDALLVYYFPLHPDHNVNLLAKKIIQYVKNIVENEVVNYKDEIIKLIVDTI 280


>gnl|CDD|235724 PRK06178, PRK06178, acyl-CoA synthetase; Validated.
          Length = 567

 Score = 27.3 bits (61), Expect = 6.9
 Identities = 8/27 (29%), Positives = 14/27 (51%)

Query: 4   LSHDRLGQFSLTTKGHGECVKFVRDLN 30
           + H R  ++ L++      V FV+ LN
Sbjct: 314 MDHPRFAEYDLSSLRQVRVVSFVKKLN 340


>gnl|CDD|179614 PRK03633, PRK03633, putative MFS family transporter protein;
           Provisional.
          Length = 381

 Score = 26.9 bits (60), Expect = 8.9
 Identities = 10/22 (45%), Positives = 12/22 (54%)

Query: 65  LLVLGGGGYTLRNVARCWTYET 86
           L +LG  G+TL  VA  W  E 
Sbjct: 292 LFILGAAGFTLYPVAMAWACEK 313


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.318    0.139    0.427 

Gapped
Lambda     K      H
   0.267   0.0624    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 11,034,576
Number of extensions: 1041275
Number of successful extensions: 1011
Number of sequences better than 10.0: 1
Number of HSP's gapped: 996
Number of HSP's successfully gapped: 51
Length of query: 213
Length of database: 10,937,602
Length adjustment: 93
Effective length of query: 120
Effective length of database: 6,812,680
Effective search space: 817521600
Effective search space used: 817521600
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 57 (26.0 bits)